
Kyle Cuneo
Physician · Trinity Health Muskegon
Credentials: · · · ·
History
2025–Present
Research
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Nature Medicine · 2021 · 877 citations
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
Science Translational Medicine · 2016 · 227 citations
Journal of Clinical Oncology · 2019 · First of 13 authors · 161 citations
- TL
56 papers

23 papers

13 papers
- JE
10 papers

10 papers · 1 as a resident

10 papers

8 papers

8 papers · 5 as a resident
Grants
- 1997–2028
University of Michigan Rogel Cancer Center Support Grant 2023-2028
National Cancer Institute · P30
Project lead · $715.2K · University of Michigan at Ann Arbor
Clinical trials
- 2020–2028
Principal investigator · Active not recruiting · Phase 1
University of Michigan Rogel Cancer Center
- 2012–2013
Principal investigator · Completed
University of Michigan Rogel Cancer Center
- 2009–2015
A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer
Principal investigator · Completed · Phase 2
University of Michigan Rogel Cancer Center
- 2008–2015
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
Principal investigator · Completed
University of Michigan Rogel Cancer Center




